Drug Topics
AUGUST 11, 2025
Furthermore, semaglutide has also shown benefits in decreasing blood sugar levels, promoting weight loss, and producing protective cardiovascular effects, according to Mayo Clinic. Changes in Cardiovascular Risk Factors and Health Care Expenditures Among Patients Prescribed Semaglutide. Mayo Clinic Press.
Pharmacy Times
JUNE 24, 2025
In an interview with Pharmacy Times at the 2025 Oncology Pharmacists Connect (OPC) meeting, Scott Soefje, PharmD, MBA, BCOP, director of pharmacy at Mayo Clinic, focused on the evolving role of pharmacists in healthcare, highlighting their increasing presence in outpatient settings to enhance efficiency and patient care.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 17, 2025
“The term ‘pharmacist-led care’ or ‘pharmacist-led interventions’ refers to health care services where pharmacists play a leading or central role in patient care,” they continued. 1 “These concepts cover a wide range of activities involving pharmacists directly in clinical patient care across various settings.”
Drug Topics
AUGUST 12, 2025
Mayo Clinical Proceedings: Digital Health. 2024.107804 Download Issue PDF Articles in this issue Rethinking Medication Adherence: Patient-Centered Solutions for Better Outcomes Newsletter Pharmacy practice is always changing. Contributor: medication adherence is not a zero-sum game. April 5, 2022. Gualtieri L, Rosenbluth S.
Pharmacy Times
JULY 14, 2025
TRE-515 aims to extend patient lives and elevate current standards of care by combining radioligand therapy with novel drug approaches. SHOW MORE FDA fast-tracks TRE-515 for advanced prostate cancer, combining it with radiation therapy to enhance treatment outcomes and patient care. Mayo Clinic.
Drug Topics
JULY 15, 2025
2 “These data are the first to show the combined use of tirzepatide and menopause hormone therapy significantly increases treatment effectiveness in postmenopausal women,” Regina Castaneda, MD, research fellow for the Division of Endocrinology at the Mayo Clinic, said in a release. said in a release. References 1. News Release.
Pharmacy Times
JUNE 19, 2025
1 Biomarker testing is relatively new in the treatment landscape for NSCLC but has proven incredibly important for personalizing patient care, transforming from a generic chemotherapy approach to a highly personalized, genomically driven treatment strategy.
Expert insights. Personalized for you.
Let's personalize your content